Citadel Advisors’s Stantec STN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,400
Closed -$368K 15210
2024
Q2
$368K Sell
4,400
-1,200
-21% -$97.8K ﹤0.01% 8705
2024
Q1
$465K Sell
5,600
-1,600
-22% -$131K ﹤0.01% 8556
2023
Q4
$577K Buy
7,200
+5,300
+279% +$368K ﹤0.01% 7775
2023
Q3
$123K Buy
+1,900
New +$126K ﹤0.01% 10631
2023
Q1
Sell
-2,100
Closed -$101K 15482
2022
Q4
$101K Buy
+2,100
New +$101K ﹤0.01% 11208

Other funds holding STN

Citadel Advisors's STN Position: Q2 2026 in Review

Citadel Advisors reduced its Stantec (STN) stake by 1.8% in Q2 2026, selling an estimated $451K and leaving 301,457 shares worth $20.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2533.

Citadel Advisors first reported a position in STN in Q1 2015 and has held it in 25 quarters since. The position peaked at $26.5M in Q1 2026. 290 funds tracked by Wall St. Rank hold STN as of Q2 2026.

  • Citadel Advisors held 301,457 shares of Stantec worth $20.8M as of Q2 2026.
  • Citadel Advisors sold 5,597 Stantec shares in Q2 2026, an estimated $451K.
  • Stantec made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #2533 holding.
  • Citadel Advisors first reported a position in Stantec in Q1 2015 and has held it in 25 quarters since.
  • Citadel Advisors's Stantec position peaked at $26.5M in Q1 2026.
  • 290 funds tracked by Wall St. Rank held Stantec as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.